The DOMUS study protocol: a randomized clinical trial of accelerated transition from oncological treatment to specialized palliative care at home

• Published in: BMC palliative care Vol. 13; no. 1; p. 44
• Main Authors: Nordly, Mie, Benthien, Kirstine Skov, Von Der Maase, Hans, Johansen, Christoffer, Kruse, Marie, Timm, Helle, Vadstrup, Eva Soelberg, Kurita, Geana Paula, von Heymann-Horan, Annika Berglind, Sjøgren, Per
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 09.09.2014; BioMed Central
• Subjects: Analysis; Home care; Hospice care; Palliative care; Study Protocol; Palliative treatment; Randomized controlled trial; Patient care; Cancer; Home care services; Specialized palliative care
• ISSN: 1472-684X; 1472-684X
• DOI: 10.1186/1472-684X-13-44

The focus of Specialized Palliative Care (SPC) is to improve care for patients with incurable diseases and their families, which includes the opportunity to make their own choice of place of care and ultimately place of death. The Danish Palliative Care Trial (DOMUS) aims to investigate whether an accelerated transition process from oncological treatment to continuing SPC at home for patients with incurable cancer results in more patients reaching their preferred place of care and death. The SPC in this trial is enriched with a manualized psychological intervention. DOMUS is a controlled randomized clinical trial with a balanced parallel-group randomization (1:1). The planned sample size is 340 in- and outpatients treated at the Department of Oncology at Copenhagen University Hospital. Patients are randomly assigned either to: a) standard care plus SPC enriched with a standardized psychological intervention for patients and caregivers at home or b) standard care alone. Inclusion criteria are incurable cancer with no or limited antineoplastic treatment options. Programs that facilitate transition from hospital treatment to SPC at home for patients with incurable cancer can be a powerful tool to improve patients' quality of life and support family/caregivers during the disease trajectory. The present study offers a model for achieving optimal delivery of palliative care in the patient's preferred place of care and attempt to clarify challenges. Clinicaltrials.gov Identifier: NCT01885637.